Osaic Holdings’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-11,878
| Closed | -$831 | – | 8190 |
|
|
2025
Q3 | $831 | Sell |
11,878
-100
| -0.8% | -$29 | ﹤0.01% | 7420 |
|
|
2025
Q2 | $4.55K | Sell |
11,978
-576
| -5% | -$494 | ﹤0.01% | 6595 |
|
|
2025
Q1 | $13.1K | Sell |
12,554
-74
| -0.6% | -$134 | ﹤0.01% | 5638 |
|
|
2024
Q4 | $12.4K | Buy |
12,628
+1,165
| +10% | +$1.45K | ﹤0.01% | 5645 |
|
|
2024
Q3 | $16.8K | Sell |
11,463
-1,600
| -12% | -$2.35K | ﹤0.01% | 5482 |
|
|
2024
Q2 | $17.6K | Sell |
13,063
-22
| -0.2% | -$33 | ﹤0.01% | 5425 |
|
|
2024
Q1 | $21.5K | Sell |
13,085
-121
| -0.9% | -$210 | ﹤0.01% | 5322 |
|
|
2023
Q4 | $25.5K | Sell |
13,206
-9,910
| -43% | -$18.4K | ﹤0.01% | 5360 |
|
|
2023
Q3 | $55.5K | Buy |
23,116
+8,705
| +60% | +$23.1K | ﹤0.01% | 4926 |
|
|
2023
Q2 | $36.8K | Sell |
14,411
-20
| -0.1% | -$53 | ﹤0.01% | 5135 |
|
|
2023
Q1 | $23.5K | Sell |
14,431
-3,903
| -21% | -$15.6K | ﹤0.01% | 5484 |
|
|
2022
Q4 | $50K | Buy |
18,334
+14,364
| +362% | +$41.7K | ﹤0.01% | 4937 |
|
|
2022
Q3 | $15K | Buy |
3,970
+1,105
| +39% | +$6.97K | ﹤0.01% | 5799 |
|
|
2022
Q2 | $16K | Buy |
2,865
+41
| +1% | +$342 | ﹤0.01% | 5780 |
|
|
2022
Q1 | $62K | Buy |
2,824
+591
| +26% | +$6.63K | ﹤0.01% | 4943 |
|
|
2021
Q4 | $33K | Buy |
2,233
+33
| +2% | +$721 | ﹤0.01% | 5451 |
|
|
2021
Q3 | $65K | Sell |
2,200
-331
| -13% | -$11.7K | ﹤0.01% | 4917 |
|
|
2021
Q2 | $116K | Sell |
2,531
-1,190
| -32% | -$57.3K | ﹤0.01% | 4367 |
|
|
2021
Q1 | $223K | Buy |
3,721
+3,283
| +750% | +$224K | ﹤0.01% | 3639 |
|
|
2020
Q4 | $23K | Buy |
438
+109
| +33% | +$5.26K | ﹤0.01% | 5071 |
|
|
2020
Q3 | $12K | Sell |
329
-146
| -31% | -$9.25K | ﹤0.01% | 5191 |
|
|
2020
Q2 | $41K | Buy |
475
+465
| +4,650% | +$34.5K | ﹤0.01% | 4335 |
|
|
2020
Q1 | $1K | Buy |
+10
| New | +$630 | ﹤0.01% | 5927 |
|
Osaic Holdings's UBX Position: Q4 2025 in Review
Osaic Holdings sold out of Unity Biotechnology (UBX) in Q4 2025, closing a stake of 11,878 shares — an estimated $831 sold.
Osaic Holdings first reported a position in UBX in Q1 2020 and held it in 23 quarters. The position peaked at $223K in Q1 2021. 0 funds tracked by Wall St. Rank hold UBX as of Q4 2025.
- Osaic Holdings reported no remaining Unity Biotechnology position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 11,878 Unity Biotechnology shares in Q4 2025, an estimated $831.
- Osaic Holdings first reported a position in Unity Biotechnology in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's Unity Biotechnology position peaked at $223K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.